Selexipag uptravi
Ended Awarded Last action
- Contract number
- 36C26018N0505
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $75,686
Award facts
- Contract value 100% obligated
- $75,685.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$10,834 | |
| Original award | $86,520 |
About this award
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract is for the drug SELEXIPAG (UPTRAVI), which is used to treat pulmonary arterial hypertension. The contract has a ceiling value of $75,685.55 and an ultimate completion date of October 10, 2018. This BPA call is part of a larger $219,108,390 multiple-award Federal Supply Schedule (FSS-61-IB) contract between the VA and Actelion, as well as two additional BPAs valued at $118.5 million and $83.5 million. These contracts allow the VA and other federal agencies to streamline the procurement of Actelion's specialized pharmaceutical products, which are essential treatments for veterans and other eligible federal beneficiaries. The contract did not utilize a small business set-aside.
Quick answers
Who was awarded contract 36C26018N0505?
36C26018N0505 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 1, 2018.
How much is contract 36C26018N0505 worth?
The government has obligated $75,686 on 36C26018N0505.
Is contract 36C26018N0505 an order under another contract?
Yes. 36C26018N0505 is a BPA call under V797P5160B-VA797P16A0015, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26018N0505 competed?
The extent of competition for 36C26018N0505 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award